Proposed Data Collection Submitted for Public Comment and Recommendations, 62859-62861 [2022-22508]
Download as PDF
<![CDATA[
62859
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
conferences for the dental public health
community. The word ’’state’’ is used to
indicate U.S. states, the District of
Columbia, U.S. territories, and other
U.S.-associated jurisdictions, except
where explicitly noted otherwise.
In 1994, ASTDD originated the annual
Synopses of Dental Programs to share
information among dental directors and
partners. The Synopses of State Oral
Health Programs (hereby referred to as
State Synopses) described program
activities and successes and the
challenges that programs faced during
the previous year. In 1997, ASTDD
changed the format to a more structured
questionnaire. Since 1998, ASTDD has
been supported to collect data through
cooperative agreements with CDC. This
collection is necessary because no other
agency or entity produces similar
analyses or reports, and the Synopsis
questionnaire is the only national data
collection source tracking states’ efforts
to improve oral health and contributions
to progress toward the national targets
for Healthy People objectives for oral
health.
OMB approval is requested for three
years. CDC requests approval for an
estimated 299 annual burden hours.
Participation is voluntary and there are
no costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State Oral Health Director or designated program contact.
Synopses of State Dental Public Health Programs.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–22503 Filed 10–14–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–23AA; Docket No. CDC–2022–
0122]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled DELTA
Achieving Health Equity through
Addressing Disparities (AHEAD)
Cooperative Agreement Evaluation. This
project aims to collect information from
DELTA AHEAD recipients to assess
implementation and program impact,
and to further understand the
facilitators, barriers, and other critical
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
VerDate Sep<11>2014
17:35 Oct 14, 2022
Jkt 259001
factors associated with program
activities.
DATES: CDC must receive written
comments on or before December 16,
2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0122 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
51
Number of
responses per
respondent
1
Average
burden per
response
(in hours)
352/60
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
DELTA Achieving Health Equity
through Addressing Disparities
(AHEAD) Cooperative Agreement
Evaluation—New—National Center for
Injury Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
E:\FR\FM\17OCN1.SGM
17OCN1
62860
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
Background and Brief Description
The goal of this project is to collect
monitoring data for performance and
implementation of the cooperative
agreement: Domestic Violence
Prevention Enhancement and
Leadership Through Alliances (DELTA)
Achieving Health Equity through
Addressing Disparities (AHEAD). The
Centers for Disease Control and
Prevention (CDC) seeks OMB approval
for three years for a new information
collection request to collect information
from 22 recipients (State Domestic
Violence Coalitions) and all 32 subrecipients (Coordinated Community
Response Teams) funded through CDC’s
DELTA AHEAD Program cooperative
agreement. CDC will collect information
from DELTA AHEAD recipients as part
of its program evaluation to assess the
implementation and impact of the
Notice of Funding Opportunity (NOFO)
and further understand the facilitators,
barriers, and critical factors to
implement specific violence prevention
strategies and conduct program
evaluation activities.
Intimate Partner Violence (IPV) is a
serious, yet preventable public health
problem that affects millions of people
in the United States each year. Data
from CDC’s 2015 National Intimate
Partner and Sexual Violence Survey
(NISVS) indicate that about one in four
women and one in 10 men have
experienced contact sexual violence,
physical violence, and/or stalking by an
intimate partner during their lifetime
and reported some form of IPV-related
impact. This form of violence
disproportionately affects marginalized
populations in the United States.
Evidence suggests an increase in new
cases and severity of IPV, particularly
for marginalized groups, during the
COVID–19 pandemic pointing to the
need to adapt IPV prevention strategies
during shutdowns and other national
reduce risk factors for and/or increase
protective factors against IPV.
Authorized by the Family Violence and
Prevention Services Act (FVPSA), CDC
has funded the DELTA Program since
2002. The DELTA program funds State
Domestic Violence Coalitions (SDVCs)
to implement statewide IPV prevention
efforts and assist and fund local
communities to do the same.
The information collection and
reporting requirements have been
carefully designed to align with and
support the specific goals and outcomes
outlined in the cooperative agreement.
This funding opportunity includes two
funding options. Category A recipients
will have existing high capacity to
implement primary prevention
strategies and will build upon existing
efforts. Category B recipients will focus
on gathering publicly available data to
better understand gaps in IPV
prevention resources, building capacity
to implement and evaluate IPV primary
prevention in their state and selected
communities, and using evaluation data
for quality improvement.
Using recipients’ annually submitted
progress, outcomes, performance
indicators, and related measures, CDC
will aggregate and synthesize those data
to inform the CDC evaluation of the
cooperative agreement initiative across
all recipients to capture program impact
at the community and state levels, as
well as performance monitoring and
continuous program improvement. The
CDC evaluation will inform and
highlight the progress and achievements
that recipients are making toward
reducing IPV using community and
societal level primary prevention
approaches in addressing risk and
protective factors.
CDC requests OMB approval for an
estimated 962 annual burden hours.
There are no costs to respondents other
than their time to participate.
and global emergencies. Such
disparities in the risk of IPV are created
and maintained through systemic health
and social inequities. To achieve health
equity requires addressing root causes
(e.g., discrimination and biases in
societal values, public policy) that
differentially disadvantage groups based
on characteristics such as race,
ethnicity, gender, and ability, and are
often expressed as racism, sexism, and
disability discrimination.
Information to be collected will
provide crucial data for program
performance monitoring and provide
CDC with the capacity to respond in a
timely manner to requests for
information about the program from the
Department of Health and Human
Services (HHS), the White House,
Congress, and other sources.
Information to be collected will also
strengthen CDC’s ability to monitor
awardee progress, provide data-driven
technical assistance, and disseminate
the most current surveillance data on
unintentional and intentional injuries.
Monitoring the impact of populationbased strategies and identifying new
insights and innovative solutions to
health problems are two of the noted
public health activities that all public
health systems should undertake. For
NCIPC, these objectives cannot be
satisfied without the systematic
collection of data and information from
state health departments. The
information collection will enable the
accurate, reliable, uniform, and timely
submission to NCIPC of each awardee’s
progress report and injury indicators,
including strategies and performance
measures. Funded recipients are
expected to use data to identify
populations and environments at
differential risk for violence due to
inequitable access to conditions needed
for health and safety. By increasing
equitable access to Social Determinants
of Health (SDOH), funded recipients
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
DELTA AHEAD State Domestic Violence.
Coalition (SDVC) Project Leads .......
Annual Performance Report ............
22
4
10
880
Key Informant Interview—Project
Lead.
Key Informant Interview—Evaluator
Prevention Infrastructure Assessment.
Sub-recipient Survey ........................
22
2
30/60
22
22
22
2
3
30/60
20/60
22
22
32
2
15/60
16
...........................................................
........................
........................
........................
962
DELTA AHEAD SDVC Evaluators ....
DELTA AHEAD SDVC staff ..............
DELTA AHEAD Coordinated Community Response Team (CCRT)
Staff.
Total ...........................................
VerDate Sep<11>2014
17:35 Oct 14, 2022
Jkt 259001
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
E:\FR\FM\17OCN1.SGM
17OCN1
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–22508 Filed 10–14–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission on Childhood
Vaccines Meeting
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Advisory Commission on
Childhood Vaccines (ACCV) provides
advice and recommendations to the
Secretary of HHS (Secretary) on policy,
program development, and other issues
related to the implementation of the
National Vaccine Injury Compensation
Program (VICP) and concerning other
matters as described under the Public
Health Service Act. To ensure
compliance with the statutory
requirement that the ACCV meet not
less than four times per year, this notice
announces that the ACCV meeting
originally scheduled for March 3, 2022,
has been rescheduled for December 2,
2022.
DATES: The ACCV meeting will be held
on December 2, 2022, from 1:00 p.m.–
4:00 p.m. Eastern Time.
ADDRESSES: This meeting will be held
by Zoom webinar.
• Webinar link: https://hrsagov.zoomgov.com/j/1603695024?
pwd=ZG4rUWw
0NUlTN2d0OWRZWVJjVmNIZz09.
• Conference call-in number: 833 568
8864, Meeting ID: 160 369 5024,
Passcode: 72471327.
FOR FURTHER INFORMATION CONTACT: Pita
Gomez, Principal Staff Liaison, ACCV,
5600 Fishers Lane, Rockville, Maryland
20857, telephone: (301) 945–9386 or
email: ACCV@HRSA.gov.
SUPPLEMENTARY INFORMATION: All 2022
ACCV meetings were originally
announced in the Federal Register, Vol.
87, No. 20 on Monday, January 31, 2022,
(FR Doc. 2022–01848 Filed 1–28–22),
and the notice canceling the March 3,
2022, meeting was published on
February 28, 2022 (FR Doc. 2022–04127
Filed 2–25–22).
Since priorities dictate ACCV meeting
times, be advised that start times, end
times, and agenda items are subject to
change. Agenda items may include but
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:35 Oct 14, 2022
Jkt 259001
are not limited to, updates from the
Division of Injury Compensation
Programs (HRSA), Torts Branch
(Department of Justice), Office of
Infectious Disease and HIV/AIDS Policy
(HHS), Immunization Safety Office
(Centers for Disease Control and
Prevention), National Institute of
Allergy and Infectious Diseases
(National Institutes of Health) and
Center for Biologics, Evaluation and
Research (Food and Drug
Administration). Refer to the ACCV
website at https://www.hrsa.gov/
advisory-committees/vaccines/
index.html for all current and updated
information concerning the ACCV
meeting, including draft agendas and
meeting materials that will be posted 5
calendar days before the meeting.
The ACCV meeting will be public,
and members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to the ACCV
should be sent to Pita Gomez using the
contact information above at least 5
business days before the meeting date.
Individuals who need special
assistance or another reasonable
accommodation should notify Pita
Gomez using the contact information
listed above at least 10 business days
before the meeting they wish to attend.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–22486 Filed 10–14–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: Health Center
Program Forms OMB No. 0915–0285
Revision
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
SUMMARY:
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
62861
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this ICR should be
received no later than December 16,
2022.
Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Information Collection Clearance
Officer, Room 14N136B, 5600 Fishers
Lane, Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Samantha Miller, the acting
HRSA Information Collection Clearance
Officer at (301) 443–9094.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Health Center Program Forms, OMB No.
0915–0285 Revision.
Abstract: The Health Center Program,
administered by HRSA, is authorized
under section 330 of the Public Health
Service (PHS) Act (42 U.S.C. 254b).
Health centers are community-based
and patient-directed organizations that
deliver affordable, accessible, quality,
and cost-effective primary health care
services to patients regardless of their
ability to pay. Nearly 1,400 health
centers operate approximately 14,000
service delivery sites that provide
primary health care to more than 30
million people in every U.S. state, the
District of Columbia, Puerto Rico, the
U.S. Virgin Islands, and the Pacific
Basin. HRSA uses forms for new and
existing health centers and other entities
to apply for various grant and non-grant
opportunities, renew grant and nongrant designations, report progress, and
change their scopes of project.
Need and Proposed Use of the
Information: Health Center Programspecific forms are necessary for award
processes and oversight of the Health
Center Program and other relevant
programs. These forms provide HRSA
staff and objective review committee
panels with information essential for
application evaluation, funding
recommendation and approval,
designation, and monitoring. These
forms also provide HRSA staff with
information essential for evaluating
compliance with Health Center Program
statutory and regulatory requirements.
ADDRESSES:
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Pages 62859-62861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22508]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-23AA; Docket No. CDC-2022-0122]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled DELTA Achieving Health Equity through Addressing Disparities
(AHEAD) Cooperative Agreement Evaluation. This project aims to collect
information from DELTA AHEAD recipients to assess implementation and
program impact, and to further understand the facilitators, barriers,
and other critical factors associated with program activities.
DATES: CDC must receive written comments on or before December 16,
2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0122 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
DELTA Achieving Health Equity through Addressing Disparities
(AHEAD) Cooperative Agreement Evaluation--New--National Center for
Injury Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
[[Page 62860]]
Background and Brief Description
The goal of this project is to collect monitoring data for
performance and implementation of the cooperative agreement: Domestic
Violence Prevention Enhancement and Leadership Through Alliances
(DELTA) Achieving Health Equity through Addressing Disparities (AHEAD).
The Centers for Disease Control and Prevention (CDC) seeks OMB approval
for three years for a new information collection request to collect
information from 22 recipients (State Domestic Violence Coalitions) and
all 32 sub-recipients (Coordinated Community Response Teams) funded
through CDC's DELTA AHEAD Program cooperative agreement. CDC will
collect information from DELTA AHEAD recipients as part of its program
evaluation to assess the implementation and impact of the Notice of
Funding Opportunity (NOFO) and further understand the facilitators,
barriers, and critical factors to implement specific violence
prevention strategies and conduct program evaluation activities.
Intimate Partner Violence (IPV) is a serious, yet preventable
public health problem that affects millions of people in the United
States each year. Data from CDC's 2015 National Intimate Partner and
Sexual Violence Survey (NISVS) indicate that about one in four women
and one in 10 men have experienced contact sexual violence, physical
violence, and/or stalking by an intimate partner during their lifetime
and reported some form of IPV-related impact. This form of violence
disproportionately affects marginalized populations in the United
States. Evidence suggests an increase in new cases and severity of IPV,
particularly for marginalized groups, during the COVID-19 pandemic
pointing to the need to adapt IPV prevention strategies during
shutdowns and other national and global emergencies. Such disparities
in the risk of IPV are created and maintained through systemic health
and social inequities. To achieve health equity requires addressing
root causes (e.g., discrimination and biases in societal values, public
policy) that differentially disadvantage groups based on
characteristics such as race, ethnicity, gender, and ability, and are
often expressed as racism, sexism, and disability discrimination.
Information to be collected will provide crucial data for program
performance monitoring and provide CDC with the capacity to respond in
a timely manner to requests for information about the program from the
Department of Health and Human Services (HHS), the White House,
Congress, and other sources. Information to be collected will also
strengthen CDC's ability to monitor awardee progress, provide data-
driven technical assistance, and disseminate the most current
surveillance data on unintentional and intentional injuries.
Monitoring the impact of population-based strategies and
identifying new insights and innovative solutions to health problems
are two of the noted public health activities that all public health
systems should undertake. For NCIPC, these objectives cannot be
satisfied without the systematic collection of data and information
from state health departments. The information collection will enable
the accurate, reliable, uniform, and timely submission to NCIPC of each
awardee's progress report and injury indicators, including strategies
and performance measures. Funded recipients are expected to use data to
identify populations and environments at differential risk for violence
due to inequitable access to conditions needed for health and safety.
By increasing equitable access to Social Determinants of Health (SDOH),
funded recipients reduce risk factors for and/or increase protective
factors against IPV. Authorized by the Family Violence and Prevention
Services Act (FVPSA), CDC has funded the DELTA Program since 2002. The
DELTA program funds State Domestic Violence Coalitions (SDVCs) to
implement statewide IPV prevention efforts and assist and fund local
communities to do the same.
The information collection and reporting requirements have been
carefully designed to align with and support the specific goals and
outcomes outlined in the cooperative agreement. This funding
opportunity includes two funding options. Category A recipients will
have existing high capacity to implement primary prevention strategies
and will build upon existing efforts. Category B recipients will focus
on gathering publicly available data to better understand gaps in IPV
prevention resources, building capacity to implement and evaluate IPV
primary prevention in their state and selected communities, and using
evaluation data for quality improvement.
Using recipients' annually submitted progress, outcomes,
performance indicators, and related measures, CDC will aggregate and
synthesize those data to inform the CDC evaluation of the cooperative
agreement initiative across all recipients to capture program impact at
the community and state levels, as well as performance monitoring and
continuous program improvement. The CDC evaluation will inform and
highlight the progress and achievements that recipients are making
toward reducing IPV using community and societal level primary
prevention approaches in addressing risk and protective factors.
CDC requests OMB approval for an estimated 962 annual burden hours.
There are no costs to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
DELTA AHEAD State Domestic Annual 22 4 10 880
Violence. Performance
Report.
Coalition (SDVC) Project Leads Key Informant 22 2 30/60 22
Interview--Proj
ect Lead.
DELTA AHEAD SDVC Evaluators... Key Informant 22 2 30/60 22
Interview--Eval
uator.
DELTA AHEAD SDVC staff........ Prevention 22 3 20/60 22
Infrastructure
Assessment.
DELTA AHEAD Coordinated Sub-recipient 32 2 15/60 16
Community Response Team Survey.
(CCRT) Staff.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 962
----------------------------------------------------------------------------------------------------------------
[[Page 62861]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-22508 Filed 10-14-22; 8:45 am]
BILLING CODE 4163-18-P
